Probable Stevens–Johnson Syndrome During Taletrectinib Treatment After Crizotinib‐Related Rash in <scp>ROS1</scp> ‐Positive Lung Cancer
- DOI
- 10.1002/rcr2.70782
- Published
- 2026-10-29
- Container
- Respirology Case Reports
- Publisher
- Wiley
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1002/rcr2.70782,
title = {Probable Stevens–Johnson Syndrome During Taletrectinib Treatment After Crizotinib‐Related Rash in
<scp>ROS1</scp>
‐Positive Lung Cancer},
author = {Hirotoshi Yasui and Ryo Fukaura and Miyu Misaki and Souma Usui and Saho Katsumata and Ryo Niimi and Ko Ohara and Kaito Sano and Yasutaka Mori and Tomofumi Shibata and Yasutaka Fukui and Mitsuru Odate and Yasushi Makino},
year = {2026},
journal = {Respirology Case Reports},
doi = {10.1002/rcr2.70782},
url = {https://doi.org/10.1002/rcr2.70782}
}RIS
TY - JOUR
TI - Probable Stevens–Johnson Syndrome During Taletrectinib Treatment After Crizotinib‐Related Rash in
<scp>ROS1</scp>
‐Positive Lung Cancer
AU - Hirotoshi Yasui
AU - Ryo Fukaura
AU - Miyu Misaki
AU - Souma Usui
AU - Saho Katsumata
AU - Ryo Niimi
AU - Ko Ohara
AU - Kaito Sano
AU - Yasutaka Mori
AU - Tomofumi Shibata
AU - Yasutaka Fukui
AU - Mitsuru Odate
AU - Yasushi Makino
PY - 2026
JO - Respirology Case Reports
DO - 10.1002/rcr2.70782
UR - https://doi.org/10.1002/rcr2.70782
ER - APA
Yasui, H., Fukaura, R., Misaki, M., Usui, S., Katsumata, S., Niimi, R., Ohara, K., Sano, K., Mori, Y., Shibata, T., Fukui, Y., Odate, M., & Makino, Y. (2026). Probable Stevens–Johnson Syndrome During Taletrectinib Treatment After Crizotinib‐Related Rash in <scp>ROS1</scp> ‐Positive Lung Cancer. Respirology Case Reports. https://doi.org/10.1002/rcr2.70782
Source records
- crossref · retrieved 2026-11-08T13:04:00.861Z